Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diligence Bio is a GLP-certified preclinical contract research organization based in Pondicherry, India. The company specializes in regulatory toxicology studies for pharmaceuticals, agrochemicals, industrial chemicals, cosmetics products and feed additives. It offers both in vivo and in vitro testing services compliant with OECD GLP standards. The facility conducts acute toxicity studies (oral/dermal/inhalation), irritation/sensitization tests, mutagenicity/genotoxicity assays (Ames test etc.), ecotoxicity assessments (fish/honey bee/earthworm/algae/daphnia/avian), and physico-chemical analyses. The company is focused on providing alternatives to animal testing models aligned with the 3Rs principle (Replace/Reduce/Refine).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diligence Bio.